Press Releases

PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics

PrecisionLife and Nanopharmaceutics, Inc. has announced today a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system assets.

BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory

BullFrog AI Holdings, Inc. announced the expansion of its worldwide license agreement with the Johns Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, for use of patented technology powering the Company’s bfLEAP™ platform, an AI-driven platform for analyzing drug development data to potentially make life-saving therapies and treatments available to patients more quickly.

MIB Agents’ Community of Families Has Awarded Over $1.5M in Grants to Research Pediatric Bone Cancer

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.

Breaking Barriers in Clinical Trials: AI and Automation as a Catalyst for Innovation

This article highlights how AI and automation are driving innovation in clinical trial research by improving patient outcomes, reducing costs, and overcoming traditional barriers to progress.

AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio

AntlerA Therapeutics has announced a strategic collaboration and licensing agreement with EyeBio to begin clinical testing of AntlerA's Norrin/Wnt-agonist, a treatment of leaky blood vessels in the eye.

Unique molecule life cycle platform released: Torx® 2.0

Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.

SMi discloses £6 million seed funding round, bolsters team with new C-suite hire

SMi Systems has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.

Sygnature Discovery launches its LPS in vivo model to profile early-stage anti-inflammatory drugs

Inizio Prioritizes Medical Excellence and Transformation with New Senior Appointment

Inizio Medical has announced a top-level hire in its senior leadership team, with the appointment of Shauna Aherne as President of Medical Excellence, Specialized Services.

BioIVT to Highlight its Expanded ADME-Tox Products and Services Portfolio at the European ISSX and DMDG Meeting

Dr. Joanna Barbara, Site Lead at BioIVT’s laboratory in Kansas City, will also present case studies that demonstrate how to account for complications like protein binding and drug instability in drug transporter studies.

CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research

Pioneering Research Unveils Dynamic Human Eye Architecture: A Breakthrough in Ophthalmology

A groundbreaking study has taken a significant step towards understanding the complexities of the human eye. By mapping the molecular architecture of the retinal pigment epithelium (RPE) and choroid – integral components of the visual system – the research provides crucial insights into the cell compositions and molecular mechanisms underlying the eye's changes with age and region.

Indica Labs Launches Comprehensive Management Service for HALO® Software in AWS Cloud-Hosted Environments

Indica Labs today announces the launch of a service offering deployment and on-going support of its HALO® digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS).

Phastar Statistics Manager Wins Prestigious DIA Award

Phastar Statistics Manager Wins Prestigious DIA Award Stephen Corson chosen to receive the DIA 2023 Global Inspire Award for Community Engagement. London, UK and Durham, NC – 6 June 2023: Stephen Corson, Statistics Manager at specialist biometrics contract research organization (CRO) Phastar, has been chosen to receive the DIA 2023 Global Inspire Award for Community Engagement.

Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden

Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden Strategic partnership integrates next-generation patient support and payment solutions for participants and sites alike

BioIVT to Host an Advanced In Vitro ADME Strategies Symposium in Copenhagen

Presenters will discuss the ICH M12 Drug Interaction Studies Guideline, and novel ADME models and methodologies.

Abzena appoints Thomas Castellano as Chief Financial Officer

Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Thomas Castellano, as Chief Financial Officer.

Inizio launches strategic engagement offering to transform customer experiences

AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology

AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology Integration of AARDEX MEMS AS and MEMS Mobile technology with Mevia's Medose dispenser offers opportunity to pilot next stage in reusable and real-time adherence solutions.

Test Environment as a Service Market is anticipated to register a CAGR of 23.5% during the forecast period.

Test Environment as a Service Market is anticipated to register a CAGR of 23.5% during the forecast period.The global test environment as a service market is expected to register moderate growth over the forecast period. This is attributed to Increasing adoption of test environment as a service, owing to it allows speeding up software release schedules, to cut infrastructure costs, and increase team productivity. Furthermore, rising utilization of test environment as a service for testing services drives growth of the global test environment as a service market.